Building on more than five decades in Hong Kong, Johnson & Johnson is committed to advancing better health through science, innovation and collaboration for patients and communities in Hong Kong.
The partnership will help strengthen clinical research, develop future healthcare talent and support Hong Kong's ambition to become a leading international health and medical innovation hub.
HONG KONG, Oct. 22, 2026 /PRNewswire/ -- Johnson & Johnson today announced that it has been selected as a Strategic Enterprise by the Hong Kong SAR Government's Office for Attracting Strategic Enterprises (OASES), marking a new chapter in the company's long-standing collaboration with Hong Kong. Johnson & Johnson sees strong alignment with Hong Kong's Five-Year Plan ambition to develop Hong Kong into a Health and Medical Innovation Hub with global influence. Building on more than five decades in the city, Johnson & Johnson will work alongside government, healthcare institutions, academia and ecosystem partners to advance health and medical innovation, strengthen clinical research and support the development of future healthcare talent.
The Financial Secretary, Mr. Paul Chan (left), and Mr. Donatas Grabliauskas, General Manager, Johnson & Johnson Innovative Medicine Hong Kong & Macau (right). Photo credit: OASES.
Since 1971, Johnson & Johnson has been proud to serve patients in Hong Kong through its Innovative Medicine and MedTech businesses. Today, the company continues to bring together global scientific expertise, innovation capabilities and local partnerships to help address some of the world's most pressing health challenges, with a particular focus on areas including oncology, immunology, neuroscience, cardiovascular disease, surgery and vison.
Hong Kong's world-class healthcare institutions, strong clinical research environment, internationally connected scientific community and growing health and medical innovation ecosystem provide a unique platform for advancing healthcare innovation and delivering meaningful benefits for patients.
The Deputy Financial Secretary, Mr. Michael Wong (centre), and Mr. Donatas Grabliauskas, General Manager, Johnson & Johnson Innovative Medicine Hong Kong & Macau (left). Photo credit: OASES.
Through its collaboration with OASES and partners across the healthcare ecosystem, Johnson & Johnson looks forward to:
Strengthening Clinical Research and Scientific Exchange
Johnson & Johnson aims to build on Hong Kong's strengths in clinical excellence by supporting opportunities for clinical research and scientific collaboration. Through partnerships with healthcare institutions, researchers and the broader innovation ecosystem, the company hopes to help connect local expertise with regional and global innovation networks.
Supporting the Development of Future Healthcare Talent
Johnson & Johnson recognizes that talent is essential to the future of healthcare innovation. The company looks forward to exploring opportunities to support education, practical learning experiences, scientific exchange and knowledge sharing that help develop the next generation of healthcare and life sciences professionals.
Advancing Meaningful and Differentiated Innovation for Patients
Guided by its belief that health is everything, Johnson & Johnson will continue working with stakeholders across the healthcare ecosystem to explore opportunities that support timely patient access to meaningful innovation in areas of significant unmet need. The company remains committed to helping improve individual patient health outcomes and creating lasting value for patients, healthcare professionals and society.
Donatas Grabliauskas, General Manager, Johnson & Johnson Innovative Medicine Hong Kong & Macau, said:
"We are honored to become an OASES Strategic Enterprise and deepen our longstanding partnership with Hong Kong. This collaboration reflects a shared commitment to advancing health and medical innovation, strengthening research and developing the next generation of healthcare talent. By working alongside the HKSAR Government and partners across the healthcare ecosystem, we hope to harness the best of Hong Kong's strengths and Johnson & Johnson's global expertise to advance health innovation and make a meaningful difference in the lives of patients, families and communities across Hong Kong."
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com or at www.innovativemedicine.jnj.com. Janssen Research & Development, LLC, and Janssen Biotech, Inc., are Johnson & Johnson companies.
Learn more at https://www.jnj.com/ or at https://www.innovativemedicine.jnj.com/.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration
Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration
Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration
SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Visa, a global leader in digital payments and the Singapore Tourism Board (STB) have signed a three-year Memorandum of Understanding (MOU) to strengthen Singapore's appeal as a preferred travel destination and to unlock new growth opportunities. The collaboration will focus on three key pillars – driving discovery of Singapore's tourism products, especially its dining and night-time experiences; deriving insights to identify high-value tourism opportunities; and developing co-branded marketing campaigns to build brand preference for both Visa and Singapore.
Visa also announced that Singapore will be part of Visa Destinations, and the collaboration will leverage Visa Destinations as a platform to introduce strategic partnerships, flagship initiatives and experiences across Singapore's tourism precincts and high-yield traveller segments.
Visa Destinations is a global travel programme designed to elevate how travellers discover and experience the world's most iconic destinations. Singapore is the second country to launch Visa Destinations in Asia Pacific, following Thailand which was introduced in July this year. Other cities include London, New York, and Paris, reinforcing the city's position as a leading travel hub. The programme will commence in Singapore in November this year.
Curating distinctively local experiences to inspire discovery of Singapore
The first pillar of collaboration will focus on benefits and experiences for travellers across tourism industries including attractions, dining, entertainment, retail and tours, which are key categories of spend.
Visa's data shows that shopping and dining are significant contributors to traveller spend. This reinforces the importance of curating meaningful experiences that give travellers compelling reasons to return to Singapore, particularly as repeat visitors spend approximately four times more than first-time visitors[1]. Visa's spend trend data and insights can sharpen the understanding of visitor segments, source markets and experiences with the greatest potential to drive higher-value demand, deeper exploration and repeat travel.
Visa and STB will also work closely to curate offers that showcase local businesses across tourism precincts, including building on an existing partnership with Pelago by Singapore Airlines to promote attractions and tours, supported by seamless, secure payment experiences throughout the visitor journey. These include introducing benefits and experience packages for Visa cardholders globally through the Visa Destinations platform at key attractions in Singapore.
The partnership will also spotlight Singapore's vibrant night-time experiences, with both parties collaborating to drive demand, including building on an existing collaboration with Grab. Singapore's night-time dynamism is a compelling part of its destination appeal, with flagship events such as the Singapore Grand Prix creating opportunities for visitors to experience the city after dark. The latest data from Visa indicated that during the F1™[2] Singapore Night Race 2026 race week, there was uplift in spend on restaurant and entertainment categories by two-thirds. Spending grew throughout the day, where evening spend climbed by almost half between 7pm and 11pm, and nearly doubled between 11pm and 5am[3].
Harnessing insights and targeted campaigns to drive high-value tourism
The second pillar will focus on harnessing tourism insights to identify high-value tourism opportunities through rich insights from Visa's global network of cardholder data and analytics capabilities.
Visa data shows that some of the largest inbound travel corridors to Singapore amongst Visa cardholders include Australia, Indonesia, Mainland China, Malaysia and the United States[4]. This aligns with STB's visitor arrival data, where these markets are among the largest source markets of visitors to Singapore. As there are common markets of interest, pooling available market data will allow both parties to develop a deeper understanding of visitor behaviour and preferences, tailor more targeted initiatives in response, and ensure efforts are focused on markets and segments with the highest potential for high-value tourism growth.
The third pillar of cooperation will see Visa and STB develop co-branded marketing campaigns anchored on the brand strengths of Visa Destinations and STB's Passion Made Possible. The partners will roll out initiatives across key source markets, supported by destination-led storytelling, co-marketing activities and in-destination activations. These efforts will combine tailored travel content with exclusive access and experiences for Visa cardholders, building on the success of past campaigns such as Visa-STB-Pelago's 'Seasons. Made in Singapore' and 'Non-stop Fun' which built on STB's 'Made in Singapore' and 'We Don't Wait For Fun' campaigns.
"Singapore is already a world-class destination with strong global appeal. Our partnership with the Singapore Tourism Board is about converting that appeal into deeper engagement, bringing together STB's destination expertise with Visa's global network, travel insights and partnerships to inspire more international travellers to visit and return," said Adeline Kim, Group Country Manager, Regional Southeast Asia, & SVP, Global Clients, Asia Pacific, Visa. "Visa Destinations will help turn inspiration into action by connecting our cardholders with benefits, exclusive access and distinctive experiences across attractions, dining, entertainment, retail and tours. Together, we can make every stage of the journey more rewarding and seamless, while helping visitors discover more of Singapore and supporting the country's ambition for high-value tourism growth," she added.
"As travellers today increasingly seek more personalised and distinctive experiences, Singapore continues to evolve to inspire new discoveries with every visit. This partnership with Visa brings together its global reach, insights and network of partners with STB's destination expertise to curate compelling, high-quality experiences and data-driven marketing campaigns that resonate with travellers' interests. Through this collaboration, we aim to create more opportunities for our tourism businesses and advance STB's Tourism 2040 priorities through impactful, high-quality tourism growth," said Melissa Ow, Chief Executive, Singapore Tourism Board.
To see the list of Singapore's Visa Destinations' benefits and experiences, click here.
***
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, sellers, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
About the Singapore Tourism Board
The Singapore Tourism Board (STB) is the lead development agency for tourism, one of Singapore's key economic sectors. Together with industry partners and the community, we shape a dynamic Singapore tourism landscape. We bring the Passion Made Possible brand to life by differentiating Singapore as a vibrant destination that inspires people to share and deepen their passions.
More: www.stb.gov.sg or www.visitsingapore.com | Follow us: STB LinkedIn, STB Facebook or STB Instagram
| [1] VisaNet data as of April 2025 to March 2026 |
| [2] Visa has no commercial affiliation or sponsorship relationship with Formula 1TM. All insights and data provided are based on VisaNet data from during the week of the Singapore Grand Prix |
| [3] VisaNet data as of event week is 5–11 October 2026, compared with the weekly average of the 52-week benchmark period from 6 October 2025 to 4 October 2026 |
| [4] VisaNet data as of September 2026 |
[1] VisaNet data as of April 2025 to March 2026
[2] Visa has no commercial affiliation or sponsorship relationship with Formula 1TM. All insights and data provided are based on VisaNet data from during the week of the Singapore Grand Prix
[3] VisaNet data as of event week is 5–11 October 2026, compared with the weekly average of the 52-week benchmark period from 6 October 2025 to 4 October 2026
[4] VisaNet data as of September 2026
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Visa Partners Singapore Tourism Board to Strengthen Singapore's Global Destination Appeal
